PT  - JOURNAL ARTICLE
AU  - Davanzo, Gustavo G.
AU  - Codo, Ana C.
AU  - Brunetti, Natalia S.
AU  - Boldrini, Vinícius
AU  - Knittel, Thiago L.
AU  - Monterio, Lauar B.
AU  - de Moraes, Diogo
AU  - Ferrari, Allan J. R.
AU  - de Souza, Gabriela F.
AU  - Muraro, Stefanie P.
AU  - Profeta, Gerson S.
AU  - Wassano, Natália S.
AU  - Santos, Luana N.
AU  - Carregari, Victor C.
AU  - Dias, Arthur H. S.
AU  - Virgilio-da-Silva, João Victor
AU  - Castro, Ícaro
AU  - Silva-Costa, Lícia C.
AU  - Palma, Andre
AU  - Mansour, Eli
AU  - Ulaf, Raisa G.
AU  - Bernardes, Ana F.
AU  - Nunes, Thyago A.
AU  - Ribeiro, Luciana C.
AU  - Agrela, Marcus V.
AU  - Moretti, Maria Luiza
AU  - Buscaratti, Lucas I.
AU  - Crunfli, Fernanda
AU  - Ludwig, Raissa G.
AU  - Gerhardt, Jaqueline A.
AU  - Seste-Costa, Renata
AU  - Forato, Julia
AU  - Amorin, Mariene R.
AU  - Texeira, Daniel A. T.
AU  - Parise, Pierina L.
AU  - Martini, Matheus C.
AU  - Bispo-dos-Santos, Karina
AU  - Simeoni, Camila L.
AU  - Granja, Fabiana
AU  - Silvestrini, Virginia C.
AU  - de Oliveira, Eduardo B.
AU  - Faça, Vitor M.
AU  - Carvalho, Murilo
AU  - Castelucci, Bianca G.
AU  - Pereira, Alexandre B.
AU  - Coimbra, Laís D.
AU  - Rodrigues, Patricia B.
AU  - Gomes, Arilson Bernardo S. P.
AU  - Pereira, Fabrício B.
AU  - Santos, Leonilda M. B.
AU  - Sposito, Andrei C.
AU  - Carvalho, Robson F.
AU  - Vieira, Andre S.
AU  - Vinolo, Marco A. R.
AU  - Damasio, André
AU  - Velloso, Licio A.
AU  - Nakaya, Helder I.
AU  - Marques-Souza, Henrique
AU  - Marques, Rafael E.
AU  - Martins-de-Souza, Daniel
AU  - Skaf, Munir S.
AU  - Proença-Modena, José Luiz
AU  - Moraes-Vieira, Pedro M.
AU  - Mori, Marcelo A.
AU  - Farias, Alessandro S.
TI  - SARS-CoV-2 Uses CD4 to Infect T Helper Lymphocytes
AID  - 10.1101/2020.09.25.20200329
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.25.20200329
4099  - http://medrxiv.org/content/early/2020/09/27/2020.09.25.20200329.short
4100  - http://medrxiv.org/content/early/2020/09/27/2020.09.25.20200329.full
AB  - The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent of a major global outbreak of respiratory tract disease known as coronavirus disease-2019 (COVID-19). SARS-CoV-2 infects the lungs and may cause several immune-related complications such as lymphocytopenia and cytokine storm which are associated with the severity of the disease and predict mortality1,2. The mechanism by which SARS-CoV-2 infection may result in immune system dysfunction is not fully understood. Here we show that SARS-CoV-2 infects human CD4+ T helper cells, but not CD8+ T cells, and is present in blood and bronchoalveolar lavage T helper cells of severe COVID-19 patients. We demonstrated that SARS-CoV-2 spike glycoprotein (S) directly binds to the CD4 molecule, which in turn mediates the entry of SARS-CoV-2 in T helper cells in a mechanism that also requires ACE2 and TMPRSS2. Once inside T helper cells, SARS-CoV-2 assembles viral factories, impairs cell function and may cause cell death. SARS-CoV-2 infected T helper cells express higher amounts of IL-10, which is associated with viral persistence and disease severity. Thus, CD4-mediated SARS-CoV-2 infection of T helper cells may explain the poor adaptive immune response of many COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from FAEPEX-UNICAMP (#2295/20, #2458/20, #2266/20 and #2274/20), Sao Paulo Research Foundation (FAPESP) (#2019/16116-4, #2019/06372-3, #2020/04583-4, #2013/08293-7, #2020/04579-7, #2015/15626-8, #2018/14933-2, #2020/04746-0, #2019/00098-7, #2020/04919-2, #2017/01184-9), the National Institute of Science and Technology in Neuroimmunomodulation (INCT-NIM) (#465489/2014-1) and FINEP (#01.20.0003.00). A.S.F. and M.A.M. were supported by CNPq productivity awards (#306248/2017-4 and #310287/2018-9). A.J.R.F, G.G.D., A.C.C., N.S.B., L.B.M., F.C., V.C.C., A.B., T.L.K, G.S.P., R.G.L. were supported by FAPESP fellowships (#2019/17007-4, #2019/22398-2, #2019/05155-9, #2019/06459-1, #2019/04726-2, #2017/23920-9, #2016/24163-4, #2016/23328-0). V.O.B. and L.N.S. were supported by FAEPEX fellowship (#2295/20 and #2319/20). D.M. was supported by CAPES fellowship. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The present study was approved by the University of Campinas Committee for Ethical Research (CAAE number 32078620.4.0000.5404). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are storage in the university databank and will be provided under reasonable request.